Not applicableStudy completedNCT04721262What this trial is testingFerumoxytol Enhanced Hyperfine Low Field Strength MRIWho this might be right forAnemia, Hemolytic University of Pennsylvania 2
Testing effectiveness (Phase 2)Study completedNCT00776503What this trial is testingVorinostat and Low Dose Cytarabine for High Risk MyelodysplasiaWho this might be right forMyelodysplastic Syndromes Groupe Francophone des Myelodysplasies 52
Not applicableStudy completedNCT01422824What this trial is testingAn Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on HaemodialysisWho this might be right forAnemia, Kidney Disease, Chronic Hoffmann-La Roche 185
Testing effectiveness (Phase 2)UnknownNCT03823079What this trial is testingComparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With ThrombocytopeniaWho this might be right forRecurrent Colorectal CarcinomaThrombopenia Fudan University 50
Testing effectiveness (Phase 2)Study completedNCT00037596What this trial is testingStudy Evaluating Gemtuzumab Ozogamicin in Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Study completedNCT02441686What this trial is testingPhase II Study of Efficacy and Safety of Lenalidomide, Subcutaneous Bortezomib and Dexamethasone Therapy for Newly Diagnosed Multiple MyelomaWho this might be right forMultiple Myeloma Dana-Farber Cancer Institute 46
Not applicableStudy completedNCT01544686What this trial is testingAntimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer PatientsWho this might be right forBloodstream Infection University of Cologne 630
Testing effectiveness (Phase 2)Study completedNCT00098670What this trial is testingFludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic LeukemiaWho this might be right forB-cell Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic Leukemia+2 more National Cancer Institute (NCI) 102
Early research (Phase 1)Active Not RecruitingNCT05362773What this trial is testingMGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesWho this might be right forLeukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more MacroGenics 130
Testing effectiveness (Phase 2)Study completedNCT00315705What this trial is testingClofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.Who this might be right forAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaRelapsed Leukemia Genzyme, a Sanofi Company 50
Not applicableLooking for participantsNCT07579065What this trial is testingHematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCTWho this might be right forHematologic NeoplasmHematopoietic Stem Cell TransplantationSurvivorship+1 more Azienda USL Reggio Emilia - IRCCS 40
Not applicableEnded earlyNCT00578292What this trial is testingAllogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLOWho this might be right forThalassemia Baylor College of Medicine 10
Testing effectiveness (Phase 2)Study completedNCT00047021What this trial is testingCombination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or LymphomaWho this might be right forLeukemiaLymphoma Case Comprehensive Cancer Center 3
Not applicableStudy completedNCT00900406What this trial is testingCollecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more Vanderbilt-Ingram Cancer Center 190
Early research (Phase 1)Ended earlyNCT05038644What this trial is testingXmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic LeukemiaWho this might be right forAcute Myeloid LeukemiaT Cell Acute Lymphoblastic LeukemiaT Cell Lymphoblastic Lymphoma Ehab L Atallah 22
Early research (Phase 1)Temporarily pausedNCT05993611What this trial is testingAllogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell TransplantationWho this might be right forChronic Graft Versus Host DiseaseHematologic and Lymphocytic DisorderSteroid Refractory Graft Versus Host Disease City of Hope Medical Center 27
Not applicableStudy completedNCT00824798What this trial is testingGait Evaluation in Haemophiliac PatientsWho this might be right forHemophilia AHemophilia B Cliniques universitaires Saint-Luc- Université Catholique de Louvain 31
Testing effectiveness (Phase 2)Looking for participantsNCT07605416What this trial is testingTesting an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM TrialWho this might be right forPlasma Cell Leukemia National Cancer Institute (NCI) 74
Early research (Phase 1)Ended earlyNCT03582033What this trial is testingA Safety Study of SEA-BCMA in Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Seagen Inc. 83
Testing effectiveness (Phase 2)Study completedNCT01703104What this trial is testingThe Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell AnemiaWho this might be right forSickle Cell Anemia Lagos State University 150